RxSight (RXST) Inventory (2020 - 2026)

RxSight (RXST) has reported Inventory for 7 consecutive years, with $39.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Inventory rose 49.19% year-over-year to $39.9 million; the trailing twelve-month figure through Jun 2026 stood at $39.9 million (up 49.19% YoY), and the FY2025 full-year result was $33.5 million, up 48.22% from the prior year.
• Inventory rose to $39.9 million in Q2 2026 per RXST's latest filing, from $36.7 million in the prior quarter.
• Across five years, Inventory topped out at $39.9 million in Q2 2026 and bottomed at $8.7 million in Q1 2022.
• Historically, Inventory has averaged $22.3 million across 5 years, with a median of $19.7 million in 2023.
• The sharpest annual moves came in 2023 and 2024: Inventory surged 113.28% in 2023, then advanced 4.44% in 2024.
• Over 5 years, Inventory stood at $15.5 million in 2022, then advanced by 15.83% to $17.9 million in 2023, then advanced by 26.26% to $22.6 million in 2024, then surged by 48.22% to $33.5 million in 2025, then climbed by 18.95% to $39.9 million in 2026.
• According to Business Quant data, Inventory over the past three periods registered $39.9 million, $36.7 million, and $33.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.